Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-11-22

Clinical Trial Update: Careseng 1370 for Healthy Volunteers [Phase 1]

View source ↗

Summary

Phase 1 trial of Careseng 1370 in healthy volunteers was terminated, with trial results posted by sponsor i Cure Biotech.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Careseng 1370

Snippet

Sponsor: i Cure Biotech Co., Ltd. | Conditions: Chemotherapy-induced Myelosuppression | Phase 1 | Status: TERMINATED | Results posted: 2024-11-22